@article {Jin2020.03.20.20039834, author = {Cheng Jin and Weixiang Chen and Yukun Cao and Zhanwei Xu and Xin Zhang and Lei Deng and Chuansheng Zheng and Jie Zhou and Heshui Shi and Jianjiang Feng}, title = {Development and Evaluation of an AI System for COVID-19 Diagnosis}, elocation-id = {2020.03.20.20039834}, year = {2020}, doi = {10.1101/2020.03.20.20039834}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Early detection of COVID-19 based on chest CT will enable timely treatment of patients and help control the spread of the disease. With rapid spreading of COVID-19 in many countries, however, CT volumes of suspicious patients are increasing at a speed much faster than the availability of human experts. Here, we propose an artificial intelligence (AI) system for fast COVID-19 diagnosis with an accuracy comparable to experienced radiologists. A large dataset was constructed by collecting 970 CT volumes of 496 patients with confirmed COVID-19 and 260 negative cases from three hospitals in Wuhan, China, and 1,125 negative cases from two publicly available chest CT datasets. Trained using only 312 cases, our diagnosis system, which is based on deep convolutional neural network, is able to achieve an accuracy of 94.98\%, an area under the receiver operating characteristic curve (AUC) of 97.91\%, a sensitivity of 94.06\%, and a specificity of 95.47\% on an independent external verification dataset of 1,255 cases. In a reader study involving five radiologists, only one radiologist is slightly more accurate than the AI system. The AI system is two orders of magnitude faster than radiologists and the code is available at https://github.com/ChenWWWeixiang/diagnosis_covid19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Zhejiang University special scientific research fund for COVID-19 prevention and control.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets from Wuhan Union hospital, Western Campus of Wuhan Union Hospital, and Jianghan Mobile Cabin Hospital were used under the license of the current study and are not publicly available. Applications for access to the LIDC-IDRI database can be made at https://wiki.cancerimagingarchive.net/display/Public/LIDC-IDRI. ILD-HUG database can be accessed at http://medgift.hevs.ch/wordpress/databases/ild-database/.}, URL = {https://www.medrxiv.org/content/early/2020/03/23/2020.03.20.20039834}, eprint = {https://www.medrxiv.org/content/early/2020/03/23/2020.03.20.20039834.full.pdf}, journal = {medRxiv} }